Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The wound environment components represent a complex, multi-faceted milieu consisting of cells, signaling molecules, and the extracellular matrix (ECM) that collectively coordinate tissue repair (StatPearls, Wound Healing, 2023). Key cellular participants include fibroblasts, keratinocytes, and various immune cells like macrophages, which transition from pro-inflammatory to pro-remodeling phenotypes to facilitate closure (NIH, PMC4150575). The acellular component is dominated by ECM proteins such as collagen and fibronectin, which provide structural support and biochemical cues for cell migration and proliferation (PubMed, 26139479). In pathological states like diabetic foot ulcers or pressure sores, the environment becomes stalled in a chronic inflammatory phase characterized by high levels of matrix metalloproteinases (MMPs) that degrade essential growth factors (Journal of Investigative Dermatology, 2007). Therapeutic strategies targeting this environment include the application of exogenous growth factors like Becaplermin or enzymatic debriders like collagenase to remove inhibitory necrotic tissue (FDA, Regranex Label). Because this term refers to a broad physiological system rather than a single molecular entity, it is generally considered a therapeutic setting or microenvironment rather than a specific drug target.
Modulation of the inflammatory phase, enzymatic debridement of necrotic tissue, and provision of growth factors or scaffolds to promote cellular proliferation and extracellular matrix synthesis.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Wound environment components.